semaglutide alcohol use disorder clinical trial Low-dose semaglutide reduced the amount of alcohol consumed - Semaglutideand addiction alcohol use Semaglutide: A Promising Frontier in Alcohol Use Disorder Treatment - Clinical Trial Insights

Once-weeklysemaglutidein adults withalcohol use disorder The journey to effectively treat Alcohol Use Disorder (AUD) is continually evolving, and recent clinical trial research is highlighting the significant potential of semaglutide, a drug primarily known for its roles in diabetes management and weight loss. Emerging evidence suggests that this GLP-1 receptor agonist may offer a novel therapeutic avenue for individuals struggling with alcohol consumption and related challenges. This article delves into the findings of various studies, providing a comprehensive overview of semaglutide's impact on alcohol use disorder.

The Growing Body of Evidence: Clinical Trials Unveiling Semaglutide's Efficacy

A notable clinical trial, a randomized clinical trial, published in *JAMA Psychiatry*, investigated the effects of once-weekly semaglutide in adults diagnosed with Alcohol Use Disorder. This early-Phase II human laboratory trial, employing a randomized, placebo-controlled, dose-ranging design, found that participants receiving semaglutide experienced substantial reductions in their alcohol consumption. Specifically, low-dose semaglutide reduced the amount of alcohol consumed during laboratory self-administration tasks. Furthermore, the study indicated a medium effect on reducing alcohol intake作者：CS Hendershot·2025·被引用次数：149—Low-dose semaglutide reduced the amount of alcohol consumedduring a posttreatment laboratory self-administration task, with evidence of medium ....

Another significant trial, referencing the work of Hendershot et al2025年2月7日—Can adrugalready hailed for its ability to help with diabetes and promote weight loss also help people withalcohol use disorderreduce .... (2025), assessed the effects of subcutaneous semaglutide on alcohol consumption in adults with Alcohol Use Disorder. The findings from this randomized clinical trial revealed that semaglutide not only reduced overall drinking, but also associated cravings. Participants often reported significantly lower levels of weekly alcohol craving throughout the study period.GLP-1 drugs, like semaglutide, lower risk of ... This observation is crucial, as reducing the desire to drink is a key component in managing AUD.Associations of semaglutide with incidence and recurrence ...

The USC-led trial confirms side effect that semaglutide, also recognized by brand names like Ozempic and Wegovy, could be beneficial for individuals aiming to decrease their alcohol intake.2025年2月7日—Can adrugalready hailed for its ability to help with diabetes and promote weight loss also help people withalcohol use disorderreduce ... This aligns with the broader understanding of GLP-1 and alcohol use disorder, suggesting a potential class-wide effect.Does weight loss, diabetes drug semaglutide cut alcohol ... While semaglutide is a prominent focus, other GLP-1 agonists, such as Exenatide once weekly for alcohol use disorder, have also been investigated in similar randomized, placebo-controlled trials, further solidifying the therapeutic potential of this drug class.

Quantifying the Impact: Specific Parameters and Verifiable Information

The impact of semaglutide appears to extend beyond general reductions in alcohol consumption. Various studies have highlighted specific quantitative improvements:

* Reduced Drinks Per Drinking Day: Research indicates that semaglutide reduced drinks per drinking day, a critical metric for assessing the severity of drinking patterns.

* Decreased Heavy Drinking Days: A significant outcome observed in several trials is the reduction in heavy drinking days, a vital indicator of progress in managing Alcohol Use Disorder.

* Lowered Peak Breath Alcohol Concentration: Studies have shown that semaglutide resulted in lower peak breath alcohol concentrations post-treatment, suggesting a physiological impact on alcohol metabolism or absorption.Repurposing Semaglutide and Liraglutide for Alcohol Use ...

* Reduced Alcohol Cravings: As mentioned, a consistent finding across multiple investigations is the substantial reduction in alcohol cravings.03. Semaglutide for Alcohol Use Disorder: New RCT Data This is evidenced by self-report data and potentially by physiological markersexpert reaction to study looking at once-weekly ....

* Impact on Drinking Frequency: While some studies emphasize reductions in the amount consumed on drinking days, others have explored changes in the proportion of drinking days.Semaglutide Shows Promise in Reducing Cravings for ... Findings here can vary, but the overall trend points towards a beneficial effect on managing alcohol use.

Expert Views and the Future of AUD Treatment

Experts in the field have reacted positively to the emerging dataClinical Trial on Semaglutide Shows Promise for Treatment .... The sentiment is that this research is among the first controlled trials demonstrating the potential efficacy of GLP-1RAs in humans with Alcohol Use Disorder, building upon promising preclinical findings. The potential for repurposing semaglutide and liraglutide for alcohol use disorder is a significant development, offering hope for more effective and accessible treatment optionsRepurposing Semaglutide and Liraglutide for Alcohol Use ....

The NCT05520775 identifier points to a specific clinical trial actively investigating semaglutide for Alcohol Use Disorder. These ongoing clinical trials are crucial for further validating these initial findings and understanding the long-term effects and optimal dosing strategies.Drinking Alcohol on Semaglutide: Risks, Side Effects, & Safety

While semaglutide is primarily recognized for its role as a weight loss and diabetes drug, its efficacy in addressing alcohol use disorder is an exciting and rapidly developing area of research作者：W Wang·2024·被引用次数：123—Exenatide once weekly for alcohol use disorderinvestigated in a randomized, placebo-controlled clinical trial. JCI Insight 7, e159863 (2022) .... The scientific community is keenly watching as more clinical trials report their findings, potentially paving the way for semaglutide to become a cornerstone therapy for individuals seeking to overcome alcohol consumption challenges and achieve lasting recoveryGLP-1 drugs, like semaglutide, lower risk of .... The ongoing exploration into its multifaceted benefits underscores the dynamic nature of medical research and the continuous pursuit of better healthcare solutions.